Extended Delay to Treatment for Stage III-IV Non–Small-Cell Lung Cancer and Survival: Balancing Risks During the COVID-19 Pandemic
Nicholas R. Mayne, Simar S. Bajaj, Joseph Powell, Holly Elser, Barbara S. Civiello, Florian J. Fintelmann, Xiao Li, Chi‐Fu Jeffrey Yang
Topics & Concepts
MedicineAdenocarcinomaInternal medicineStage (stratigraphy)Proportional hazards modelLung cancerCancerHazard ratioOncologySurvival analysisLog-rank testNational Lung Screening TrialPropensity score matchingGastroenterologyLung cancer screeningConfidence intervalBiologyPaleontologyCOVID-19 and healthcare impactsLung Cancer Diagnosis and TreatmentLung Cancer Treatments and Mutations